We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Andrew
Peet
andrew.peet@bch.nhs.uk
Prof
Andrew
Peet
andrew.peet@bch.nhs.uk
Jane
Crouch
jane.crouch2@nhs.net
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The aims and objectives of the study is to:- 1) determine the changes in magnetic resonance spectroscopy (MRS) metabolic profiles from pre treatment to post radiotherapy for diffuse pontine gliomas. 2) to determine how MRS metabolic profiles differ between diffuse pontine gliomas and localised tumours/other lesions of the midbrain, pons and medulla, 3) To improve the understanding of diffuse pontine gliomas and other tumours of the brain stem through the analysis of MRS profiles
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Validation of investigation /therapeutic procedures;
You can take part if:
You may not be able to take part if:
1. Patients for whom any magnetic resonance study is contra-indicated. 2. Patients over the age of 21 years at diagnosis.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Prof
Andrew
Peet
andrew.peet@bch.nhs.uk
Jane
Crouch
jane.crouch2@nhs.net
Prof
Andrew
Peet
andrew.peet@bch.nhs.uk
The study is sponsored by University of Birmingham and funded by CANCER RESEARCH UK; Engineering and Physical Sciences Research Council (EPSRC); Medical Research Council (MRC); NATIONAL INSTITUTE FOR HEALTH AND CARE RESEARCH; .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 1498
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
